This inventor holds 2 USPTO granted patents. Top assignees: American Home Products Corporation, Wyeth. Active years: 2001-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2009
Title: Brendan William Bingham: Innovator in Chemokine Receptor Research
Introduction
Brendan William Bingham is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of biotechnology, particularly in the study of chemokine receptors and neuronal pathways. With a total of two patents to his name, Bingham's work has implications for both human and canine health.
Latest Patents
Bingham's latest patents include the "Synthetic dog/human chimeric C-C chemokine receptor 2B." This patent discloses polynucleotides encoding a chimeric C-C chemokine receptor 2B, along with the methods of making and using these polynucleotides and polypeptides. Another significant patent is related to "Neuronal MORT1 isoforms." This patent describes a MORT1 gene initially cloned from HeLa cells, which is expressed in the human neuronal cell line, NTERA2. The isolation of MORT1 from this cell line revealed a transcript isoform that differs from the known MORT1 sequence by a deletion of 21 base pairs. Cloning of MORT1 from adult human brain tissue revealed two isoforms, one with a similar deletion and another with a base pair substitution. Assessment of MORT1 function indicates that these isoforms differ in their capacity to interact with other members of the apoptotic pathway.
Career Highlights
Throughout his career, Bingham has worked with prominent companies such as Wyeth and American Home Products Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Bingham has collaborated with notable coworkers, including Smita Atul Kotnis and Jeffrey Dale Kennedy. These collaborations have likely enriched his research and development efforts.
Conclusion
Brendan William Bingham is a distinguished inventor whose work in chemokine receptors and neuronal pathways has the potential to impact both human and canine health. His patents reflect a commitment to advancing scientific knowledge and innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile